About Abacus Medicine
Abacus Medicine is a company based in Copenhagen (Denmark) founded in 2004 by John Wagner and Flemming Wagner. Abacus Medicine has raised $57.64 million across 8 funding rounds from investors including Chr. Augustinus Fabrikker. The company has 1,052 employees as of December 31, 2021. Abacus Medicine offers products and services including Parallel Imported Medicines, Clinical Trial Services, and Pharmaceutical Wholesaling. Abacus Medicine operates in a competitive market with competitors including OPEN Health, Target RWE, Secura Bio, STATinMED Research and Hylant, among others.
- Headquarter Copenhagen, Denmark
- Employees 1052 as on 31 Dec, 2021
- Founders John Wagner, Flemming Wagner
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abacus Medicine A/S
-
Annual Revenue
-
Net Profit
-$2.83 K (USD)-29as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$57.64 M (USD)
in 8 rounds
-
Latest Funding Round
$206.4 K (USD), Series B
Jul 01, 2020
- Investors
-
Employee Count
1052
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abacus Medicine
Abacus Medicine offers a comprehensive portfolio of products and services, including Parallel Imported Medicines, Clinical Trial Services, and Pharmaceutical Wholesaling.
Provides affordable prescription medicines through parallel importing for cost savings.
Offers support for clinical trials in pharmaceutical research and development.
Handles wholesale of medical devices and direct patient services across Europe.
People of Abacus Medicine
Unlock access to complete
Unlock access to complete
Software Development Team
26 people
Sales and Marketing
18 people
Finance and Accounting
12 people
Portfolio Team
12 people
Leadership Team
6 people
Human Resources and Administration
6 people
Product Management Team
6 people
Board Team
5 people
Unlock access to complete
Funding Insights of Abacus Medicine
Abacus Medicine has successfully raised a total of $57.64M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $206.4 thousand completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $206,400
-
First Round
First Round
(22 Dec 2006)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Series B - Abacus Medicine | Valuation |
investors |
|
| Sep, 2019 | Amount | Series B - Abacus Medicine | Valuation | Chr. Augustinus Fabrikker |
|
| Jun, 2019 | Amount | Series A - Abacus Medicine | Valuation |
investors |
|
Investors in Abacus Medicine
Abacus Medicine has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Chr. Augustinus Fabrikker.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abacus Medicine
Financial Statements - Abacus Medicine
Abacus Medicine Comparisons
Competitors of Abacus Medicine
Abacus Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OPEN Health, Target RWE, Secura Bio, STATinMED Research and Hylant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of healthcare marketing services
|
|
| domain | founded_year | HQ Location |
Marketing services to the pharmaceutical industry are provided.
|
|
| domain | founded_year | HQ Location |
Consulting services for market access and health outcomes are provided.
|
|
| domain | founded_year | HQ Location |
Healthcare data analytics services provider
|
|
| domain | founded_year | HQ Location |
Offers business insurance, employee benefits, and risk consulting services worldwide.
|
Frequently Asked Questions about Abacus Medicine
Abacus Medicine was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Abacus Medicine is headquartered in Copenhagen, Denmark.
Flemming Wagner is the current CEO of Abacus Medicine. They have also founded this company.
Abacus Medicine is a funded company, having raised a total of $57.64M across 8 funding rounds to date. The company's 1st funding round was a Series A of $77.65K, raised on Dec 22, 2006.
As of Dec 31, 2021, the latest employee count at Abacus Medicine is 1,052.
Abacus Medicine was founded in 2004 in Copenhagen, Denmark, within the pharmaceutical consulting sector. Services are offered in market access strategies, health economics evaluations, and outcomes research. Additional areas include strategic business development support, quality and compliance management, cGMP adherence, clinical monitoring, and pharmaceutical sales assistance. Operations focus on health-related consulting for various clients.
Abacus Medicine's top competitors include OPEN Health, Target RWE and STATinMED Research.
Abacus Medicine offers Parallel Imported Medicines, Clinical Trial Services, and Pharmaceutical Wholesaling.
Abacus Medicine has 1 investor. Key investors include Chr. Augustinus Fabrikker.
The valuation of Abacus Medicine is $20.93M as of Jul 2020.